CD8A and cancer: CAR T cells have proven effective in cancer treatment [168], and it has been speculated that arming CD8+ T cells with CARs directed towards HIV-1 proteins that are exposed on the surface of productively infected cells may improve their recognition and killing by the transgenic CD8+ cells.